Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125783361 | 12578336 | 1 | I | 20120302 | 20120923 | 20160721 | 20160721 | EXP | DE-ROCHE-1796311 | ROCHE | 37.00 | YR | M | Y | 0.00000 | 20160721 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125783361 | 12578336 | 1 | PS | Peg-Interferon Alfa 2a | PEGINTERFERON ALFA-2A | 1 | Unknown | U | 103964 | ||||||||||
| 125783361 | 12578336 | 2 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Unknown | U | 21511 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125783361 | 12578336 | 1 | Chronic hepatitis C |
| 125783361 | 12578336 | 2 | Chronic hepatitis C |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125783361 | 12578336 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125783361 | 12578336 | Decreased appetite | |
| 125783361 | 12578336 | Fatigue | |
| 125783361 | 12578336 | Hemiparesis | |
| 125783361 | 12578336 | Influenza | |
| 125783361 | 12578336 | Pruritus | |
| 125783361 | 12578336 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |